2005
DOI: 10.1128/jb.187.6.1879-1883.2005
|View full text |Cite
|
Sign up to set email alerts
|

Vacuuming the Periplasm

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
19
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(21 citation statements)
references
References 41 publications
(37 reference statements)
2
19
0
Order By: Relevance
“…They form protein complexes with a trimeric outer membrane factor OMF (Koronakis et al 2000;) and a bridging periplasmic adapter protein (Akama et al 2004;Andersen et al 2001;Higgins et al 2004) of the MFP family. This protein complex is supposed to ''vacuum-clean'' the periplasma and interior of the cytoplasmic membrane by export of toxic substances to the outside (Lomovskaya and Totrov 2005). The RND proteins drives this process as a kind of peristaltic pump (Dastidar et al 2007;Murakami et al 2006), which is driven by the proton-motive force (Goldberg et al 1999).…”
Section: Overviewmentioning
confidence: 99%
“…They form protein complexes with a trimeric outer membrane factor OMF (Koronakis et al 2000;) and a bridging periplasmic adapter protein (Akama et al 2004;Andersen et al 2001;Higgins et al 2004) of the MFP family. This protein complex is supposed to ''vacuum-clean'' the periplasma and interior of the cytoplasmic membrane by export of toxic substances to the outside (Lomovskaya and Totrov 2005). The RND proteins drives this process as a kind of peristaltic pump (Dastidar et al 2007;Murakami et al 2006), which is driven by the proton-motive force (Goldberg et al 1999).…”
Section: Overviewmentioning
confidence: 99%
“…Although at the time of this writing no agents are available for inhibition of type C ␤-lactamases, a variety of agents have been identified as having the potential to inhibit overexpressed efflux pumps of Gram-negative bacteria [10]. However, although some of these inhibitors of efflux pumps affect the function of the pump itself [efflux pump inhibitors (EPIs)] [11,12], there is now evidence that some EPIs may have an effect on regulatory genes involved in the control of efflux expression and genes that code for transporters [13,14]. Because of this, assessment of EPIs must also include their potential genetic actions.…”
Section: Introductionmentioning
confidence: 99%
“…Because P-glycoprotein is perhaps the best-studied efflux pump and has offered important insights into the mechanism of bacterial pumps (see references 8, 290, 419, 448, and 539 for a review), we will periodically refer briefly to work on this eukaryotic system. Efflux systems are now thought to play an important role in bacterial drug resistance (278,288,372). Whereas some efflux pumps are selective for a given substrate, many transporters are able to extrude a plethora of structurally unrelated drugs, conferring a multidrug resistance (MDR) phenotype (263,278).…”
Section: Drug Efflux Pumps In Bacteriamentioning
confidence: 99%